Methods and clinical biomarker discovery for targeted proteomics using Olink technology
PROTEOMICS – Clinical Applications, 2024
Wang H., Zhao T., Zeng J., Zhang R., Pu L., Qian S., Xu S., Jiang Y., Pan L., Dai X., Guo X., Han L.
| Disease area | Application area | Sample type | Products |
|---|---|---|---|
Wider Proteomics Studies | Review/editorial |
Abstract
Purpose
This paper is to offer insights for designing research utilizing Olink technology to identify biomarkers and potential therapeutic targets for disease treatment.
Experimental Design
We discusses the application of Olink technology in oncology, cardiovascular, respiratory and immune‐related diseases, and Outlines the advantages and limitations of Olink technology.
Results
Olink technology simplifies the search for therapeutic targets, advances proteomics research, reveals the pathogenesis of diseases, and ultimately helps patients develop precision treatments.
Conclusions
Although proteomics technology has been rapidly developed in recent years, each method has its own disadvantages, so in the future research, more methods should be selected for combined application to verify each other.